BeStock  
Stocks › Biotechnology › IDYA

IDEAYA Biosciences IDYA

US equityMarket cap rank #2556Biotechnology
$25.56 −$0.61 (-2.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.56 0.00%
Open$25.83
Prev close$26.17
Day range$25.46 – $26.87
Volume1.11M
Market cap$2.47B
P/E (TTM)–
Dividend yield–

IDYA Stock News

Headlines matching IDEAYA Biosciences or the IDYA ticker, most recent first.

  • Guggenheim Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $57 PositiveMarket news · 9 Sep 2026 · Direct mention
  • LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $58Market news · 28 Sep 2026 · Direct mention
  • Citi Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $65Market news · 11 Sep 2026 · Direct mention
  • Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy RatingMarket news · 1 Sep 2026 · Direct mention
  • Mizuho Securities Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $50Market news · 1 Sep 2026 · Direct mention
  • Citizens JMP Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $42Market news · 7 Aug 2026 · Direct mention
  • Wedbush Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 6 Aug 2026 · Direct mention
  • RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $48Market news · 6 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for IDEAYA Biosciences(IDYA.US), With a Forecast Between $48 to $60Market news · 5 Aug 2026 · Direct mention
  • Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $59 NegativeMarket news · 5 Aug 2026 · Direct mention
  • Wedbush Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $60Market news · 20 Aug 2026 · Direct mention
  • J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $62 NegativeMarket news · 11 Aug 2026 · Direct mention
  • Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $63Market news · 7 Jul 2026 · Direct mention
  • RBC Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 7 Jul 2026 · Direct mention
  • LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $62Market news · 27 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IDYA.

Sign in to join the discussion.

Scroll to Top